CClinicalTrials.gg
Status unknownNCT04228900Updated Jun 4, 2020

Malnutrition in Older Adults: An Intervention Based on Medication Review and Individual Nutritional Plan

An interventional study of Individualized plan for improvement of nutrition and Systematic drug review in Malnutrition, Polypharmacy and Aged, sponsored by University of Oslo. Status unknown at 1 site in Norway. Open to participants aged 70 Years and older. Per ClinicalTrials.gov, last updated 2020-06-04.

Sponsored by University of Oslo · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jun 2020), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Non-randomized
Ages
70 Years and older
Sex
All
01

Study summary

The project "Nutrition and Medication management in home-dwelling older adults" consist of two separate studies witch are described in the same study protocol. This is the second study in this Project. The first study (cross sectional) is described separately; Identification: 2017/12883-1

Undernutrition is common in older adults. The causes are many and include drug therapy. Drug side effects, as loss of appetite, nausea, or dry mouth, may contribute to malnutrition, impaired health and loss of function.

In patients with malnutrition or at risk for malnutrition we will evaluate an intervention consisting of:

  • an "individual nutritional plan" with different measures aiming at improving nutritional status.
  • a systematic drug review.
Read the detailed description

The participants will be recruited by the home nursing services or by a nurse at a short-time ward in the nursing home.

The composite intervention consists has two components (A and B):

Component A: Clinical assessment and critical medication review

Drawing on information from the medical history, clinical finding according to examination made by the principal investigator (trained physician), information from the General Practitioner (GP) and the findings from blood tests, we will make a systematic and critical medication review. This systematic review has the following considerations:

  • Are drug-drug unintended interactions likely to occur? Interaction analysis supported by https:// www.interaksjoner.no
  • Are there use of potentially inappropriate medication? Assessed based on the Norwegian General Practice Nursing -Home criteria.
  • Could nutritional related problems like loss of appetite, dry mouth and nausea, be attribute to adverse drug effects? Assessed by the list we made of drugs who often contributes to these side effects according to The Norwegian Pharmaceutical Product Compendium.

Component B: Nutritional intervention- individual nutrition plan. Drawing on the principles for good nutritional practice, and National guidelines, this component include the following considerations:

  • Nutritional status by use of Mini Nutritional Assessment short form (MNA-SF), and further in- depth nutrition assessment if MNA-SF is in range 0-11.
  • Assessment of the nutritional needs.
  • Assess food and drink intake with a 3- day dietary record to the estimated nutritional needs.
  • In collaboration with the home nurse, the participant and if possible/ necessary a next to kin, focusing on individual problems and develop an individual nutritional plan.

The project is about a controlled implementation of measures recommended in current national guidelines. We will follow a principle known as the "Nutritional Stairs", and choose interventions in the nutritional plan as close to "normal" food as possible. This means that the individual nutritional plan takes into account:

  • Physical and mental disorders are diagnosed and optimal treated. (Oral health care included)
  • Intervention to optimize the meal environment and meal itself, e.g., enough light in the room, specific tools to make eating possible if necessary, company
  • The frequency of meals, length of night fasting, special diets as energy- and nutrient dens diets, consistency customized diet (liquid or solid food)
  • Enriched food and in between meals/snacks
  • Nutritional supplements

The intervention last six months, and participants in the intervention group will receive four visits at home; baseline and after 4, 12 and 24 weeks. At baseline and at week 24, the principal investigator (trained physician) and the nurse will visit the participants. At week 4 and 12, only the nurse will visit them. The control group, are visited by a nurse twice: at baseline and after 24 weeks, and are follow-up by the home nurse service and their GP "as usual".

Drop- out during the study period and reasons for "loss to follow-up (LTFU)" will be registered; e.g., moved from the municipality, acute illness that make further participation difficult, admission to long time ward in nursing home, or any other reason to withdraw participation. In the intervention group, we will on behalf of and subject to the participant's consent, make an appointment for consultation by the GP, if the clinical assessment suggests undetected diseases or diseases not optimal treated. If oral health problems are encountered, we will recommend a consultation by a dentist.

02

Conditions studied

  • Malnutrition
  • Polypharmacy
  • Aged

Browse trials for

Keywords

  • Malnutrition
  • Polypharmacy
  • Drug side effects
  • Nutritional improvement
  • Medication review
03

In context

Malnutrition

1,587 studies on the registry are indexed under Malnutrition; 237 are open to participants now.

This study's planned enrollment of 50 is below the median of 90 across 1,134 interventional studies indexed under Malnutrition.

Browse Malnutrition studies →

Lead sponsor

University of Oslo is the lead sponsor of 176 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
70 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 70 year or more
  • Receiving home nurse care each second week or more often
  • Mini Nutritional Assessment short form (MNA-SF): 0-11 point (malnourished or at risk for malnutrition)

Exclusion criteria

Exclusion Criteria:

  • Life expectance less than 6 month
  • Serious cognitive impairment
  • In need of enteral-/ parenteral nutrition
  • Not able to stand up for weight measure
  • The home care service are not responsible for medication delivery.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Intervention group

    Drug review and tailored nutritional supply.

    Dietary Supplement: Individualized plan for improvement of nutrition · Drug: Systematic drug review

  • No intervention
    Control group

    Follow-up by home nurse service and family physician "as usual".

Interventions

  • Dietary supplementIndividualized plan for improvement of nutrition

    For each participant we will make a plan, describing different items the can improve their nutritional status: enrichment of food, dental care,

  • DrugSystematic drug review

    Consider altering medication list if the patient has symptoms that may be attributed to adverse drug effects, in particular side effects as nausea, dry mouth or loss of appetite, and if drug-drug interactions or drug-disease interactions are likely to occur. Recommended changes in patient's medication list will be presented for the family physician who will hold the final decision to implement the suggested adjustments.

06

What researchers measure

Primary outcomes

  1. Change from Baseline Body weight at 24th week

    measurement of the participants weight

    Time frame: Baseline, 24th week

Secondary outcomes

  1. Change from Baseline Health- related quality of life at 24th week

    answered by one question:"Consider your health, would you say it is: excellent(score 5)- very good (score 4)- good (score 3)- pretty good (score 2)- bad(score 1)" minimum score 1, Maximum score 5.The higher score the better.

    Time frame: Baseline, 24th week

  2. Change from Baseline Activity of Daily living (ADL) at 24th week

    Assessed by Barthel´s ADL-index. Minimum score 0, Maximum score 20. The higher score the better.

    Time frame: Baseline, 24th week

  3. Change from Baseline Admission to nursing home at 24th week

    Changes in Number of admissions to nursing home

    Time frame: Baseline, 24th week

  4. Change from Baseline Admission to hospital at 24th week

    Change in Number of admissions to hospital

    Time frame: Baseline, 24th week

  5. Change from Baseline Mini Nutritional Assessment short form (MNA-SF) at 24th week

    minimum score 0, Maximum score 14. 0-7 indicate malnutrition, 8-11 indicate risk for malnutrition, 12-14; normal nutritional status

    Time frame: Baseline, 24th week

  6. Change from Baseline Number of drugs in daily use at 24th week

    Change in number of drugs in daily use

    Time frame: Baseline, 24th week

  7. Change from Baseline Number of drugs in daily use considered inappropriate at 24th week

    Number of drugs considered inappropriate according to the Norwegian Practice Nursing-Home criteria, se protocol page 19-20,attachment 1

    Time frame: Baseline, 24th week

  8. Change from Baseline Number of drugs in daily with high risk causing nausea, loss of appetite, and dry mouth at 24th week.

    See list Protocol page 21-23, attachment 2

    Time frame: Baseline, 24th week

07

Study locations

1 site
  • Department of General Practice, Institute og Health and Society, University og Oslo
    Oslo, 4050, Norway
08

References and documents

Study documents

  • Informed consent form · Jan 7, 2019
  • Informed consent form · Jan 7, 2019
  • Informed consent form · Jan 7, 2019
  • Informed consent form · Jan 7, 2019
  • Study protocol · Dec 17, 2019

Documents are hosted by the registry — open the source record to download them.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 4, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04228900
Lead sponsor
University of Oslo
Collaborators
The Norwegian Research Fund for General Practice
Responsible party
Mari Fiske (Principal investigator, University of Oslo) — Principal investigator
First posted
Jan 14, 2020
Start date
Aug 24, 2020 (estimated)
Primary completion
Jul 2023 (estimated)
Completion
Jul 2023 (estimated)
Last update
Jun 4, 2020

Study contacts

Mari Fiske, phd
Contact
mari.fiske@medisin.uio.no
0047 92667311
Straand Jørund, Professor
Contact
jorund.straand@edisin.uio.no
0047 82852523
Straand Jørund, Professor
study chair · Institute of Health and Society, University of Oslo, Norway

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion